Activation of DDX58/RIG-I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer

Some patients with colon cancer eventually develop metastasis during treatment, and the 5-year survival rate of patients with metastatic colon cancer remains relatively low, which is most likely due to the ineffectiveness of the current standard treatment. Systemic treatment for patients with colon...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yuying, Fu, Han, Han, Xue, Li, Yuxi, Zhao, Wei, Zhao, Xuening, Yu, Chunxue, Guo, Wenqing, Lei, Kaijian, Wang, Tianxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450811/
https://www.ncbi.nlm.nih.gov/pubmed/36004488
http://dx.doi.org/10.3892/ijo.2022.5410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450811/
https://www.ncbi.nlm.nih.gov/pubmed/36004488
http://dx.doi.org/10.3892/ijo.2022.5410

Ejemplares similares